Cargando…
Elafin as a Prognostic Marker in Esophageal Squamous Cell Carcinoma: A Pilot Study Using Three-Dimensional Imaging and Genomic Profiling
SIMPLE SUMMARY: This research leveraged three-dimensional confocal imaging to examine elafin’s spatial distribution in locoregional esophageal squamous cell carcinoma (ESCC) tumors. Our findings highlighted distinct elafin localizations in patients with poor versus favorable prognoses. Elafin expres...
Autores principales: | Chen, Wei-Chung, Wu, Chun-Chieh, Liu, Yu-Peng, Zhuo, Guan-Yu, Wang, Yao-Kuang, Chen, Yi-Hsun, Chen, Chu-Chih, Wang, Yin-Han, Wu, Ming-Tsang, Wu, I-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417143/ https://www.ncbi.nlm.nih.gov/pubmed/37568641 http://dx.doi.org/10.3390/cancers15153825 |
Ejemplares similares
-
High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021) -
Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Chen, Wei-Chung, et al.
Publicado: (2022) -
High Expression and Clinical Significance of Elafin in Colorectal Cancer
por: Liu, Yun, et al.
Publicado: (2019) -
Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagus.
por: Yamamoto, S., et al.
Publicado: (1997) -
Serum Elafin as a Potential Marker of Disease Activity in Behçet's Disease
por: Kutlay, Armagan, et al.
Publicado: (2023)